Welwaze Medical Inc., the manufacturer of the innovative Celbrea® medical device for the detection of early signs of breast disease, has decided to enter the Latin American market and through its master distributor in Latin America, has chosen bioaccess™ as its regulatory and market access consulting firm to aid it in entering the Colombian market.
Read MoreAmbiance Ventures™ ("AV"), a Division of Nadkarni Media Group LLC, a Pennsylvania based advisory company specialized in managing corporate innovation and business development programs for life science companies; and bioaccess™- a Colombia and Florida based clinical research and regulatory services company, are pleased to announce a cooperation agreement for licensing innovative medical products, clinical trials regulatory processing, and marketing/distribution in Latin America.
Read MoreEmergo by UL ("Emergo"), a global medical device and healthcare technology consultancy, and bioaccess™, a medical device contract research organization and market access consultancy focused in Latin America, have announced an agreement to help each other's clients with their clinical research, regulatory compliance and market access needs in Brazil, Colombia, Costa Rica, Mexico, and Peru — some of the most attractive medical device markets in Latin America.
Read MoreSANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce that the company has appointed Interventional Concepts, Inc. to act as Territory Sales Manager for sourcing and screening of potential distributors and access to clinical trials participation for SANUWAVE's products in Colombia.
Read More